Company Performance Metrics
Robert Hamilton: Co-FounderPast Role: NovaSignal, CSO & Co-Founder
NeuraSignal specializes in the development and application of medical technology focused on brain health. By integrating robotics and artificial intelligence with transcranial Doppler ultrasound, the company offers innovative solutions for real-time monitoring of cerebral blood flow. NeuraSignal's flagship product, the NG2, is an FDA-cleared,
robot-assisted diagnostic tool designed to enhance the detection of conditions related to cerebral blood flow. The company aims to improve patient outcomes by providing healthcare professionals with critical data on brain health, facilitating early and accurate diagnosis. Data security is ensured through encrypted data transmission, compatible with hospital firewalls for safe and secure data handling.
NeuraSignal was formed in June 2023 following the acquisition of certain assets from NovaSignal.